| | | | | | | | | | | | | | | | | | | | | | | |
|
|
|
|
| 2006P-0387
|
| Declare That Clobetasol Propionate from, 0.05b0is suitable for submission in an ANDA.
|
|
|
|
|
|
|
| FDA Comment Number :
|
| EC1
|
|
|
|
|
| Submitter :
|
| Mr. Dave Lowe
|
| Date & Time:
|
| 10/18/2006 10:10:45
|
|
|
|
|
| Organization :
|
| Mr. Dave Lowe
|
|
|
|
|
| Category :
|
| Individual Consumer
|
|
|
|
|
| Issue Areas/Comments
|
|
|
|
|
|
| GENERAL
|
|
|
|
|
|
|
|
| GENERAL
|
|
|
|
|
|
|
|
| There are numerous branded names and no petition is available. Temovate and Tamovate E prescribing information is available as Attachment One and Attachment Two. Attachment Three is an electronic Orange Book search for 'Clobetasol Propionate', also showing showing Clobetasol Propionate and Temovate are available for purchase. All should be misbranded, and any action keeping all approved drugs withdrawn. I oppose the petition.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 2006P-0387-EC1-Attach-1.PDF
|
|
|
|
|
| 2006P-0387-EC1-Attach-2.PDF
|
|
|
|
|
| 2006P-0387-EC1-Attach-3.PDF
|
|